Selling depression to the world

After the SSRIs were developed, their manufacturers realized the population needed to be convinced they were suffering from depression so as many people as possible would buy their drugs

The tricks the drug industry used to perform this were remarkable and have many parallels to how the predatory pharmaceutical industry pushes many other drugs on us 

While a minority of patients (about a third) benefit from antidepressant therapy, the majority do not (termed “treatment resistant depression”), but unfortunately, until recently there have been minimal options available for these patients

Much of this results from depression being viewed as a single illness, rather than a myriad of conditions with somewhat overlapping symptoms which each need to be treated differently (rather than simply all being given the same drug)

Read the full analysis

Subscribe to Mercola for more news & videos